AYTU BIOPHARMA, INC Payments to Acquire Businesses, Gross
AYTU BIOPHARMA, INC (AYTU) reported Payments to Acquire Businesses, Gross of $0 for the 12-month period ending 2022-06-30, per its 10-K filed 2022-09-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesGross · last filed 2022-09-27
- AYTU BIOPHARMA, INC payments to acquire businesses, gross for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- AYTU BIOPHARMA, INC payments to acquire businesses, gross for the quarter ending 2016-03-31 was -$540.00K.
- AYTU BIOPHARMA, INC payments to acquire businesses, gross for the quarter ending 2015-06-30 was $1.00M.
- AYTU BIOPHARMA, INC payments to acquire businesses, gross for the quarter ending 2015-03-31 was $0.00.
- AYTU BIOPHARMA, INC payments to acquire businesses, gross for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- AYTU BIOPHARMA, INC payments to acquire businesses, gross for fiscal 2021 was $15.52M, a 165.30% increase from fiscal 2020.
- AYTU BIOPHARMA, INC payments to acquire businesses, gross for fiscal 2020 was $5.85M.
- AYTU BIOPHARMA, INC payments to acquire businesses, gross for fiscal 2018 was $297.00K.
| Period end | Payments to Acquire Businesses, Gross 1 month | Payments to Acquire Businesses, Gross 3 month | Payments to Acquire Businesses, Gross 6 month | Payments to Acquire Businesses, Gross 9 month | Payments to Acquire Businesses, Gross 9 month as first filed | Payments to Acquire Businesses, Gross 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | $0.00 10-K · filed 2022-09-27 | |||||
| 2021-06-30 | $15.52M 10-K · filed 2022-09-27 | |||||
| 2020-06-30 | $5.85M 10-K · filed 2021-09-28 | |||||
| 2018-06-30 | $297.00K 10-Q · filed 2018-11-07 | $297.00K 10-K · filed 2018-09-06 | ||||
| 2017-03-31 | $6.00M 10-Q · filed 2017-05-11 | |||||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | -$540.00K derived: sum of 2 quarters · filed 2017-05-11 | $0.00 10-K · filed 2016-09-01 | |||
| 2016-03-31 | -$540.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-11 | $0.00 10-Q · filed 2017-05-11 | $540.00K 10-Q · filed 2016-05-11 | |||
| 2015-12-31 | $540.00K 10-Q · filed 2016-02-11 | |||||
| 2015-06-30 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-01 | $1.00M derived: sum of 2 quarters · filed 2016-09-01 | $1.00M 10-K · filed 2016-09-01 | |||
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-11 | $0.00 10-Q · filed 2016-05-11 | ||||
| 2014-12-31 | $0.00 10-Q · filed 2016-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |